[1]
Mirzaei, M. et al. 2021. Evaluation of the Clinical Efficacy and Complications of Duloxetine in Comparison to Solifenacin in the Treatment of Overactive Bladder Disease in Women: A Randomized Clinical Trial. Urology Journal. 18, 05 (Aug. 2021), 543–548. DOI:https://doi.org/10.22037/uj.v18i05.6274.